| Followers | 17 |
| Posts | 1121 |
| Boards Moderated | 0 |
| Alias Born | 11/18/2023 |
Thursday, April 24, 2025 1:03:52 PM
You might be right. I got A LOT tied up into this and I really thought we had a decent 1st movers advantage position in this sector BUT that is only if Ronn and his cronies have actually been telling factual truths. At this point, after all we've been through with RONN, I'm like 80% thinking this is a cold hard scam and 20% thinking it might be true and it might work out...but only Ronn Ford, John Morgan, and Chad Curtis really know...
Recent AIMN News
- Aimwell Bio Highlights Verified Biopharma Intelligence Network Strategy Amid Growing AI Trust Concerns (AIMN) • IH Market News • 05/27/2026 03:17:48 PM
- Why a Verified Biopharma Intelligence Network Is Quietly Becoming the Credential Itself • ACCESS Newswire • 05/27/2026 12:30:00 PM
- The Quiet Restructuring of Healthcare Intelligence: Why the Industry is Moving Toward Verified Professional Networks Over Anonymous AI • ACCESS Newswire • 05/20/2026 12:30:00 PM
- Inside AimwellBio's Federated Health Intelligence Network: Verified Clinical Intelligence Model Gains Attention Among Physicians • ACCESS Newswire • 05/18/2026 12:30:00 PM
- The Doctors Saw It First. Then the Chiropractors Asked. Now AimwellBio is Adding the Four Signals Every Family in America is Quietly Searching For. • ACCESS Newswire • 05/13/2026 12:30:00 PM
- Aimwell Partners Brand, AimwellBio Announces Expanded FHIN Intelligence Framework, Early Demo Feedback, and New AIMN Development Milestones • ACCESS Newswire • 05/11/2026 12:30:00 PM
- While You Were in That Meeting, 14 Signals Moved. Your Competitors Saw Them. You Didn’t. • ACCESS Newswire • 05/06/2026 12:30:00 PM
- AimwellBio Reports Strong Early Demand From Hospital Systems and Researchers as FHIN Founding Cohort Takes Shape • ACCESS Newswire • 05/04/2026 12:30:00 PM
- AimwellBio Launches Verified Intelligence Layer for Healthcare as AI Hallucination Risk Reaches Clinical Settings • ACCESS Newswire • 04/27/2026 12:30:00 PM
- Aimwell Bio Expands FHIN Deployment Across U.S. and Australia as Clinical Leaders Move to Replace Unverified AI Hospitalists and Physician Groups Drive Demand for Source-Traceable Intelligence Infrastructure • ACCESS Newswire • 04/22/2026 12:30:00 PM
- Aimwell Bio Announces "Founding Cohort" of Federated Health Intelligence Network (FHIN); Tackles 38% AI Hallucination Rate in Biopharma • ACCESS Newswire • 04/20/2026 12:30:00 PM
- AimwellBio Launches the System That Catches What AI Gets Wrong: Before It Reaches Patients, Boards, or Your Portfolio • ACCESS Newswire • 04/15/2026 12:30:00 PM
